Latest Imugene News & Updates

See the latest news and media coverage for Imugene. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Imugene

Clinical-stage immuno-oncology company

imugene.com
Headquarters
Sydney, Australia
Founded year
2013
Company type
Public company
Number of employees
50–200

Latest news about Imugene

Company announcements

  • Imugene

    Imugene's azer-cel data selected for ASCO oral presentation

    The presentation occurs at the 2026 ASCO Annual Meeting in Chicago. Details release on April 21, 2026.

  • Imugene

    Imugene reports strong Phase 1b Azer-cel data

    Azer-cel shows 100% response rate in CLL/SLL and 80% in marginal zone lymphoma. Imugene gains media attention and CEO presents at Bell Potter Conference.

  • Imugene

    Imugene updates on azer-cel data and capital raise

    Azer-cel shows 80-100% ORR in blood cancer trials. Completed $12M placement; launched $8M SPP.

  • Imugene

    Imugene's CEO shares azer-cel progress

    She highlights complete cancer clearance in late-stage patients and encouraging response rates in pre-treated patients. The company advances toward registrational pathway.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Imugene

Track Imugene and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Imugene competitors & trending companies

Browse news for competitors to Imugene and other trending companies.